ABU DHABI/WAM Under the patronage of President His Highness Sheikh Mohamed bin Zayed Al Nahyan, ...
Read More »Concordia on the wrong side of pharma history
Max Nisen Disappointing earnings. Substantially lower guidance for 2016. A CFO departure. A suspended dividend. A drug-pricing controversy. Oh, and a libel suit against a chicken farmer. All were features of Concordia International’s unusually calamitous earnings report on Friday. For a day, at least, the Ontario-based specialty pharma firm one-upped its better-known progenitor Valeant, which has had a mixed ...
Read More »